Shringar House of Mangalsutra Ltd
SHRINGARMSShringar House of Mangalsutra Ltd is coiled. The quarters are improving, yet the P/E sits at the 25th percentile of its own 1-year range — the business is moving before the market.
The sharpest disagreement: profits are rising, but only −146% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (8 weeks in) while the P/E sits at the 25th percentile of its own 1-year range. Underneath, the last four quarters read improving — profit +17.2% year on year, and −146% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Shringar House of Mangalsutra Ltd trades at ₹223, in a confirmed uptrend and 8 weeks into that stage. That is +4.9% against its own 200-day average. It sits at 68% of a 52-week range of ₹176 to ₹246. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks.
Today the stock is in a confirmed uptrend — week 8 of stage 2, confirmed. At ₹223 it trades +4.9% versus its 200-day average and sits at 68% of its 52-week range (₹176–₹246).
Against the market, two honest reads. Cumulative: over the last 11 months the stock moved +18% while the NIFTY 500 moved +2% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 6 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Shringar House of Mangalsutra Ltd's story is not scored yet against the markers our research file set on 31 May 2026. Where it sits in its own cycle: COMPRESSED_WITH_EARNINGS_GROWTH. Our fortnightly research layers last read it on 19 July 2026.
Our read, 31 May 2026. A niche B2B mangalsutra manufacturer delivering FY26 PAT +89% YoY at PE 17.5x (79% of its own median) — bridal entry, job-work-to-outright conversion, and capacity at 4,000 kg add three new growth vectors the market has not yet priced.
From the numbers. PE 17.5x vs 10Y median 22.1x (ratio 0.791) — MEAN_REVERT_OPPORTUNITY persists. FII stake expanded from 3.36% (Dec 2025) to 5.77% (Mar 2026) — +241 bps in one quarter. Promoter stable at 74.8% across all three quarters…
From the price. Price stage 2, week 8 — above its 200-day line.
From the research. A niche B2B mangalsutra manufacturer delivering FY26 PAT +89% YoY at PE 17.5x (79% of its own median) — bridal entry, job-work-to-outright conversion, and capacity at 4,000 kg add three new growth vectors the market has…
🚨 Where they disagree. PE 17.5x vs 10Y median 22.1x (ratio 0.791) — MEAN_REVERT_OPPORTUNITY persists. FII stake expanded from 3.36% (Dec 2025) to 5.77% (Mar 2026) — +241 bps in one quarter. Promoter stable at 74.8% across all three quarters since IPO. EPS moved from Rs 8.47 (FY25) to Rs 11.98 (FY26) — +41% YoY EPS growth while PE compressed from IPO levels, confirming market is pricing in gold-normalization risk rather than earnings deterioration.
What is proven. A niche B2B mangalsutra manufacturer delivering FY26 PAT +89% YoY at PE 17.5x (79% of its own median) — bridal entry, job-work-to-outright conversion, and capacity at 4,000 kg add three new growth vectors the market has not yet priced.
What is not proven yet. FY26 volume +15% YoY while revenue +57% — gold near-doubling did ~75% of the revenue work; a 20%+ gold correction compresses reported revenue to ~Rs 1,500-1,600 Cr TTM range without any demand deterioration.
Layer 1 read, 19 July 2026 — KEEP. Real volume-led growth at a cheap multiple, but the profit isn't turning into cash — good story, weak balance-sheet quality. PE sits at the 20th percentile of its own history while net profit is expanding fast (Q4 PAT +123.5% YoY) and volume grew ~15%, the ingredients of a depressed-breakout. The problem is that three years of profit produced negative operating cash (OCF/PAT -1.46) as working-capital days ballooned 31->79, so the earnings are accrual, not cash. The +137% margin-of-safety is a trailing-DCF artifact — on normalized earnings the stock is roughly fair (mos_normal -12.89).
What would change Layer 1’s mind. Q1/Q2 FY27 turning FCF positive (milestone M3/G7) with WC days compressing back toward 30 — proving the profit converts to cash — would remove the accrual objection and re-open P1; conversely a MISS on FCF-positive at Q2 FY27 confirms the value-trap read.
Layer 2 read, 19 July 2026 — BENCH. Real cheap-PE earnings inflection, but the growth is funded by a blowing-out balance sheet in a sector flooding capacity — hold, don't deploy. Shringar is genuinely cheap (PE 20th percentile) on explosive profit and revenue growth (+127%/+107% YoY), which is why it survives as a KEEP. But the cash engine is broken — operating cash flow is deeply negative (OCF/PAT -1.46) because working-capital days blew out 31->79, and the sector's own risk read names Shringar by name for exactly this strain. With the sector capital cycle at CAPACITY_RISK (inventory/capacity flooding, institutions absent, promoters trimming) and a historical SEBI/governance flag, external evidence confirms this is a watch, not a deploy.
What would change Layer 2’s mind. One clean quarter where operating cash flow turns positive and working-capital days revert toward the ~31-day prior-3y average (reversing OCF/PAT -1.46), evidencing the job-work->outright conversion is self-funding — that would neutralize the WC Governor violation and flip BENCH->ADVANCE. Conversely, a fresh governance disclosure or a gold-correction inventory write-down would push it toward DROP.
The test written in advance. Gold Price Dependency — Volume the Key Organic Signal — Gold Price Dependency — Volume the Key Organic Signal Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices. by the next result.
The test written in advance. Management Governance — Historical SEBI Flag + Intra-Call Inconsistencies — Management Governance — Historical SEBI Flag + Intra-Call Inconsistencies by the next result.
The test written in advance. Negative FCF — Working Capital Expansion Tracking Revenue Growth — Negative FCF — Working Capital Expansion Tracking Revenue Growth by the next result.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Corporate Client Mix Shift (34% FY25 → 49%… | HIGH | — | Organized retail clients — Tata, Birla, Reliance, Malabar, Kalyan — grew from 34% of FY25 revenue to 49% of FY26 revenue… | Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices. |
| Operating Leverage (EBITDA growing at… | HIGH | — | FY26 EBITDA +72% YoY on revenue +57% YoY — fixed-cost absorption from automation investment (Italian/Turkish/Chinese machinery… | Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices. |
| Capacity Expansion (2,500 kg → 4,000 kg… | MEDIUM | — | Capacity increased 60% to 4,000 kg in Q4 FY26 with modern machinery installed; FY26 blended utilization 87% confirms demand… | Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices. |
| Bridal Jewelry Entry (new segment, Tanishq… | MEDIUM | — | Bridal commenced Q4 FY26 with Tanishq; Indriya and Malabar sequential approvals pending; management targets bridal reaching… | Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices. |
| Job-Work to Outright Conversion (3x… | MEDIUM | — | Birla, Reliance, Indriya already converted to outright; Tata actively negotiated; 0.7-ton job-work generates Rs 28 Cr labor… | Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices. |
Lever 5 · Regulatory approval — BUILDING. Organized retail clients — Tata, Birla, Reliance, Malabar, Kalyan — grew from 34% of FY25 revenue to 49% of FY26 revenue, providing payment discipline (Rs interest penalties for late payment) and repeating volume as each chain adds 50-100 stores annually. What proves it keeps working: Corporate Client Mix Shift (34% FY25 → 49% FY26, target 70-80%). It stops working if Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices.
Lever 4 · Paying down debt — BUILDING. FY26 EBITDA +72% YoY on revenue +57% YoY — fixed-cost absorption from automation investment (Italian/Turkish/Chinese machinery allowing same 100 artisans to produce 3-4x output) confirmed across 4 quarters. What proves it keeps working: Operating Leverage (EBITDA growing at ~1.1-1.2x revenue growth). It stops working if Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices.
Lever 3 · Management change — BUILDING. Capacity increased 60% to 4,000 kg in Q4 FY26 with modern machinery installed; FY26 blended utilization 87% confirms demand absorption; full 4,000 kg available for FY27. What proves it keeps working: Capacity Expansion (2,500 kg → 4,000 kg, 87% FY26 utilization). It stops working if Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices.
Lever 9 · Buyback — BUILDING. Bridal commenced Q4 FY26 with Tanishq; Indriya and Malabar sequential approvals pending; management targets bridal reaching 30-35% of mangalsutra sales by FY27 end, with bridal representing 60% of total jewelry industry. What proves it keeps working: Bridal Jewelry Entry (new segment, Tanishq launched Q4, 30-35% of mangalsutra target by FY27 end). It stops working if Quarterly volume (kg) growth — must sustain above 12% YoY to confirm organic demand independent of gold prices.
Sources: our stock research file (31 May 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Shringar House of Mangalsutra Ltd reported ₹548 Cr of revenue in the Jun 26 quarter, +64.6% year on year. That is the 5th straight quarter of year-on-year growth. Over 5 years it has compounded at 34.5% a year. The last full year, FY26, came in at ₹2,246 Cr. The last four reported quarters add to ₹2,462 Cr.
FY26 revenue came in at ₹2,246 Cr (+57.1% on the year), capping 5 years at 34.5% compound. The latest quarter (Jun 26) printed ₹548 Cr, +64.6% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +66.8% growth against the decade's 34.5% — the current year is running faster than its own long-run rate.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Shringar House of Mangalsutra Ltd's operating margin is 9.0% in the Jun 26 quarter, −3.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 6 fiscal years the operating margin has ranged 3.7% to 7.0%.
The latest quarter's operating margin is 9.0%, −3.0 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged 3.7%–7.0%, and FY26's 7.0% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −3.5 pp year on year while gross margin went −4.2 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Shringar House of Mangalsutra Ltd earned ₹34.0 Cr of net profit in the Jun 26 quarter, +17.2% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹115 Cr. The 5-year compound rate is 54.7%. That is 6.2% of the quarter's revenue. The same quarter a year earlier earned ₹29.0 Cr.
Jun 26 profit was ₹34.0 Cr, +17.2% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹115 Cr (+88.5%), and the 5-year compound rate is 54.7%.
Why profit moved: revenue contributed +64.6% and the margin −3.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +79.6% vs revenue +66.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −146% of Shringar House of Mangalsutra Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−282 Cr of operating cash against ₹115 Cr of profit. After ₹19.0 Cr of capital spending, ₹−301 Cr was left as free cash.
FY26: operating cash of ₹−282 Cr against reported profit of ₹115 Cr, leaving free cash of ₹−301 Cr after ₹19.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −146% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −146%: the cash cycle stretched 69 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 69 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Shringar House of Mangalsutra Ltd's cash conversion cycle runs 116 days in FY26, up from 47 days in FY21. Capital spending ran ₹23.0 Cr over the last 3 years. At FY26 sales of ₹2,246 Cr each day of that cycle holds about ₹6.2 Cr, so roughly ₹714 Cr sits inside the business at any moment.
FY26: debtors at 38 days, inventory at 79 days — roughly 2.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 116 days, looser than FY21's 47.
The full loop: cash goes out to suppliers and production on day 0; stock waits 79 days to sell; customers pay about 38 days after that; and suppliers themselves are paid at 2 days — netting out to the 116-day cycle.
In money terms: at FY26 sales of ₹2,246 Cr, each day of the cycle holds about ₹6.2 Cr — so the 116-day loop keeps roughly ₹714 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹23.0 Cr over the last 3 fiscal years against ₹10.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Shringar House of Mangalsutra Ltd earns a ROCE of 27% in FY26. That is up from a trough of 20% in FY23. Return on invested capital clears the cost of that capital by +4.6 percentage points, so growth here adds value rather than only size. The wiring behind it is 5.1% net margin on 2.52× asset turns.
FY26 ROCE is 27%, recovered from a FY23 trough of 20% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 5.1% net margin × 2.52× asset turns × 1.32× balance-sheet leverage ≈ 17.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 16.6% − 12.0% = a +4.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Shringar House of Mangalsutra Ltd carries total debt of ₹189 Cr against shareholder equity of ₹678 Cr as of Mar 26, a debt-to-equity of 0.28 — effectively unlevered. On the annual view that ratio went from 0.61 in FY25 to 0.28 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Why this happened. The cost structure is now differentiated from artisanal peers. The automation investment is complete; incremental volume drops to EBITDA above the blended rate. EBITDA margin expanded 61 bps in FY26. The one-time Q4 drag (MCX hedging notional losses, exhibition costs) compressed Q4 EBITDA by -41 bps YoY — but these are identifiable and recurring hedging artifacts, not margin deterioration. PAT impact per overlay: 15%.
Mar 26: total debt of ₹189 Cr against shareholder equity of ₹678 Cr — a debt-to-equity of 0.28. On the annual view, debt-to-equity went from 0.61 (FY25) to 0.28 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Shringar House of Mangalsutra Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.
Why this happened. Production constraint was the binding limit on volume growth in prior periods. The board-approved expansion was committed in Feb 2026 and executed in Q4 FY26 — on-time delivery noted. Annual production 3,500 kg (3.5 tons) in FY26 achieving 15% volume growth despite gold near-doubling. The new capacity removes the ceiling for FY27 volume ramp and enables the bridal segment launch in parallel with mangalsutra production.
The register over the last two years — .
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Shringar House of Mangalsutra Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
Why this happened. This is the primary structural driver. The organized jewellery retail expansion in India is a multi-year compounding event — mangalsutra is a culturally-mandatory item at every new store opening. Management's target of 70-80% corporate share implies 21-31pp additional mix improvement. The transition matters for both revenue quality (organized retailers honor 12-15 day payment terms vs non-organized 15-20 day slippage) and volume predictability. PAT impact per overlay: 20%.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Shringar House of Mangalsutra Ltd trades at 17.8× P/E, near the bottom of its own range — cheaper only 25% of the time. Its long-run median P/E is 20.3×, measured across 0.9 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 17.8× is near the bottom of its own range — cheaper only 25% of the time, against a long-run median of 20.3× measured over 0.9 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +41.4% against a +17.7% price move — earnings outran the price, pushing the multiple DOWN its own range.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
The PEG ratio, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Shringar House of Mangalsutra Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 5 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +57.1% | +33.2% | +34.5% | — |
| Profit | +88.5% | +71.0% | +54.7% | — |
| EPS | +41.4% | −23.1% | −57.2% | — |
| Share price | +17.7% | — | — | — |
4-Factor Sector Score
50.7/100 — rank 17 of 26 in Diamond, Gems & Jewellery · 60% evidence confidence
Shringar House of Mangalsutra Ltd scores 50.7 out of 100 against the 26 companies it is compared with in Diamond, Gems & Jewellery, ranking 17. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 15.1 + 15.5 + 10.1 + 10 = 50.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Said versus delivered
What Shringar House of Mangalsutra Ltd's management promised, set against what actually arrived — 2 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
Bridal Segment Rollout Exaggeration · 27 May 2026. During the prepared remarks of the May 2026 call, management claimed they had already commenced bridal jewelry sales through multiple marquee partners, explicitly naming both Tanishq and Malabar Gold. However, later in the Q&A section of the same call, management contradicted this claim by admitting that sales had only started with Titan (Tanishq) and that they had not yet expanded this new segment to Malabar.
Conflicting Capacity Utilization Figures · 12 February 2026. During the February 2026 call, the CEO explicitly stated that the manufacturing facility is currently operating at approximately 70% capacity utilization. However, in the subsequent Q&A session of the same call, the Chairman contradicted this statement, clarifyng that the 70% figure was actually from the previous year and that the current nine-month utilization rate is lower at 64%. Later call (Feb 2026): “Currently, our manufacturing facility has a total capacity of 2,500 kg and is working at approximately 70% capacity utilization levels, allowing us to produce a wide range of mangalsutras under one roof.” Later call (Feb 2026): “That 70% utilization was from last year”.
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Tribhovandas Bhimji Zaveri LtdTBZ | 72.2/100Favorable setup87% evidence | BREAKING OUT | 25.6/35 Revenue 29.1% · PAT 100% · OPM change 0 pp 95% evidence | 14.7/25 ROCE 21.4% · OPM 9% 95% evidence | 13.9/20 P/E 7.8× · PEG — 50% evidence | 18.0/20 RS sector 16.3% · RS bench 40.5% · 1Y 33.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.6 + 14.7 + 13.9 + 18 = 72.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2D.P. Abhushan LtdDPABHUSHAN | 69.8/100Favorable setup100% evidence | BREAKING OUT | 25.3/35 Revenue 30.8% · PAT 94.3% · OPM change 1 pp 100% evidence | 18.2/25 ROCE 39.6% · OPM 11% 100% evidence | 14.7/20 P/E 13.6× · PEG 0.68 100% evidence | 11.6/20 RS sector -9.7% · RS bench 10.4% · 1Y -12%5 of 12 weeks ahead 100% evidence |
| Exact sum: 25.3 + 18.2 + 14.7 + 11.6 = 69.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Sky Gold & Diamonds LtdSKYGOLD | 69.3/100Favorable setup97% evidence | LEADER | 27.6/35 Revenue 81.4% · PAT 100% · OPM change 2 pp 95% evidence | 15.5/25 ROCE 27% · OPM 8% 95% evidence | 7.3/20 P/E 35.8× · PEG 1.71 100% evidence | 18.9/20 RS sector 55.8% · RS bench 86.6% · 1Y 180.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 27.6 + 15.5 + 7.3 + 18.9 = 69.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Khazanchi Jewellers Ltd543953 | 69.2/100Favorable setup76% evidence | TURNING | 25.8/35 Revenue 15.7% · PAT 100% · OPM change 2 pp 95% evidence | 17.5/25 ROCE 34.8% · OPM 7% 76% evidence | 11.7/20 P/E 19.2× · PEG — 50% evidence | 14.2/20 RS sector 13.2% · RS bench 14% · 1Y 33.6%3 of 10 weeks ahead 70% evidence |
| Exact sum: 25.8 + 17.5 + 11.7 + 14.2 = 69.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 5Utssav CZ Gold Jewels LtdUTSSAV | 66.3/100Thin evidence · provisional56% evidence | LEADER | 19.7/35 Revenue — · PAT — · OPM change 0 pp 26% evidence | 18.1/25 ROCE 28.8% · OPM 7% 95% evidence | 9.6/20 P/E 20.7× · PEG — 15% evidence | 18.9/20 RS sector 54.8% · RS bench 84.3% · 1Y 158.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 18.1 + 9.6 + 18.9 = 66.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Thangamayil Jewellery LtdTHANGAMAYL | 63.9/100Mixed-positive evidence100% evidence | LEADER | 26.9/35 Revenue 83.2% · PAT 100% · OPM change -1 pp 100% evidence | 14.0/25 ROCE 25.5% · OPM 5% 100% evidence | 9.2/20 P/E 43× · PEG 0.77 100% evidence | 13.8/20 RS sector 18.4% · RS bench 42.1% · 1Y 174.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.9 + 14 + 9.2 + 13.8 = 63.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Titan Company LtdTITAN | 59.0/100Mixed-positive evidence100% evidence | BREAKING OUT | 26.9/35 Revenue 45% · PAT 55.1% · OPM change 3 pp 100% evidence | 13.4/25 ROCE 20.5% · OPM 14% 100% evidence | 7.9/20 P/E 76.9× · PEG 1.43 100% evidence | 10.8/20 RS sector -0.3% · RS bench 21.2% · 1Y 46.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 26.9 + 13.4 + 7.9 + 10.8 = 59 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Senco Gold LtdSENCO | 57.5/100Mixed-positive evidence100% evidence | ASLEEP | 24.8/35 Revenue 43.1% · PAT 100% · OPM change -3 pp 100% evidence | 12.5/25 ROCE 21.2% · OPM 7% 100% evidence | 15.1/20 P/E 9.8× · PEG 1.35 100% evidence | 5.1/20 RS sector -17.8% · RS bench 0% · 1Y 2.9%9 of 12 weeks ahead 100% evidence |
| Exact sum: 24.8 + 12.5 + 15.1 + 5.1 = 57.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17.8% and the one-year return is 2.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9Uday Jewellery Industries Ltd539518 | 56.3/100Mixed-positive evidence78% evidence | 27.2/35 Revenue 100% · PAT 100% · OPM change 3 pp 83% evidence | 14.2/25 ROCE 22.4% · OPM 7% 76% evidence | 11.9/20 P/E 13.7× · PEG — 50% evidence | 3.0/20 RS sector -18.9% · RS bench -3.8% · 1Y -1%7 of 8 weeks ahead to 2026-07-19 100% evidence | |
| Exact sum: 27.2 + 14.2 + 11.9 + 3 = 56.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -18.9% and the one-year return is -1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Kalyan Jewellers India LtdKALYANKJIL | 55.4/100Mixed-positive evidence100% evidence | BREAKING OUT | 22.4/35 Revenue 45.8% · PAT 79.3% · OPM change -1 pp 100% evidence | 11.1/25 ROCE 20.5% · OPM 6% 100% evidence | 5.0/20 P/E 42.9× · PEG 2.19 100% evidence | 16.9/20 RS sector 8% · RS bench 31.2% · 1Y 15.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 11.1 + 5 + 16.9 = 55.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Shanti Gold International LtdSHANTIGOLD | 55.2/100Mixed-positive evidence74% evidence | TURNING | 17.8/35 Revenue 100% · PAT 100% · OPM change -8 pp 95% evidence | 16.5/25 ROCE 37% · OPM 10% 95% evidence | 10.8/20 P/E 12.2× · PEG — 15% evidence | 10.1/20 RS sector -5.3% · RS bench 15.3% · 1Y 3.3%9 of 12 weeks ahead 70% evidence |
| Exact sum: 17.8 + 16.5 + 10.8 + 10.1 = 55.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12RBZ Jewellers LtdRBZJEWEL | 54.6/100Mixed-positive evidence87% evidence | TURNING | 17.5/35 Revenue 30.3% · PAT 54% · OPM change -2.3 pp 95% evidence | 16.5/25 ROCE 21.8% · OPM 14.8% 95% evidence | 13.7/20 P/E 9.9× · PEG — 50% evidence | 6.9/20 RS sector -17.8% · RS bench 0.2% · 1Y 8.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 16.5 + 13.7 + 6.9 = 54.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Vaibhav Global LtdVAIBHAVGBL | 54.5/100Mixed-positive evidence100% evidence | FADING | 19.3/35 Revenue 10.4% · PAT 73.8% · OPM change 3 pp 100% evidence | 12.8/25 ROCE 16.4% · OPM 11% 100% evidence | 18.5/20 P/E 13.4× · PEG 0.33 100% evidence | 3.9/20 RS sector -20.3% · RS bench -2.9% · 1Y 3.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 12.8 + 18.5 + 3.9 = 54.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Motisons Jewellers LtdMOTISONS | 52.6/100Mixed-positive evidence87% evidence | TURNING | 16.4/35 Revenue 10.7% · PAT 50% · OPM change 0 pp 95% evidence | 13.4/25 ROCE 17.9% · OPM 15% 95% evidence | 11.9/20 P/E 28.5× · PEG — 50% evidence | 10.9/20 RS sector -10.5% · RS bench 9.4% · 1Y -11.6%3 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 13.4 + 11.9 + 10.9 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Golkunda Diamonds & Jewellery Ltd523676 | 51.7/100Thin evidence · provisional57% evidence | 13.6/35 Revenue 1.3% · PAT -12.4% · OPM change -0.8 pp 53% evidence | 13.2/25 ROCE 19.9% · OPM 9.7% 57% evidence | 8.3/20 P/E 16× · PEG — 50% evidence | 16.6/20 RS sector 61.7% · RS bench 52.8% · 1Y 61.4%9 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 13.6 + 13.2 + 8.3 + 16.6 = 51.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16P N Gadgil Jewellers LtdPNGJL | 51.2/100Mixed-positive evidence93% evidence | TURNING | 26.0/35 Revenue 47.8% · PAT 76.6% · OPM change 2 pp 100% evidence | 12.5/25 ROCE 20.9% · OPM 8% 100% evidence | 7.9/20 P/E 20× · PEG 1.77 65% evidence | 4.8/20 RS sector -18.5% · RS bench -0.6% · 1Y 10.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 26 + 12.5 + 7.9 + 4.8 = 51.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -18.5% and the one-year return is 10.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 17Shringar House of Mangalsutra Ltdthis pageSHRINGARMS | 50.7/100Mixed-positive evidence60% evidence | FADING | 15.1/35 Revenue 65.1% · PAT 65.8% · OPM change -3 pp 95% evidence | 15.5/25 ROCE 26.8% · OPM 9% 95% evidence | 10.1/20 P/E 17.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 15.1 + 15.5 + 10.1 + 10 = 50.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bluestone Jewellery & Lifestyle LtdBLUESTONE | 48.7/100Thin evidence · provisional59% evidence | BREAKING OUT | 23.5/35 Revenue 40% · PAT 100% · OPM change 3.4 pp 74% evidence | 4.7/25 ROCE 7.1% · OPM 14.5% 100% evidence | 8.6/20 P/E 229× · PEG — 15% evidence | 11.9/20 RS sector — · RS bench 48.9% · 1Y 54.7%7 of 10 weeks ahead 25% evidence |
| Exact sum: 23.5 + 4.7 + 8.6 + 11.9 = 48.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19PC Jeweller LtdPCJEWELLER | 47.9/100Mixed-negative evidence100% evidence | TURNING | 20.1/35 Revenue 36.5% · PAT 32.7% · OPM change 10 pp 100% evidence | 6.8/25 ROCE 9.6% · OPM 28% 100% evidence | 16.3/20 P/E 12.1× · PEG 0.26 100% evidence | 4.7/20 RS sector -25.1% · RS bench -8.3% · 1Y -30.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 6.8 + 16.3 + 4.7 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Radhika Jeweltech LtdRADHIKAJWE | 46.5/100Mixed-negative evidence87% evidence | TURNING | 11.4/35 Revenue 16.9% · PAT 27% · OPM change -6 pp 95% evidence | 18.2/25 ROCE 25.1% · OPM 20% 95% evidence | 10.7/20 P/E 10.3× · PEG — 50% evidence | 6.2/20 RS sector -22.8% · RS bench -5.5% · 1Y -28%2 of 12 weeks ahead 100% evidence |
| Exact sum: 11.4 + 18.2 + 10.7 + 6.2 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21PNGS Gargi Fashion Jewellery Ltd543709 | 46.4/100Mixed-negative evidence76% evidence | ASLEEP | 8.1/35 Revenue 18.3% · PAT 8.7% · OPM change -3.5 pp 95% evidence | 19.9/25 ROCE 33.8% · OPM 19.8% 76% evidence | 10.8/20 P/E 19.3× · PEG — 50% evidence | 7.6/20 RS sector -2.3% · RS bench -36.2% · 1Y -27.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 8.1 + 19.9 + 10.8 + 7.6 = 46.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Manoj Vaibhav Gems N Jewellers LtdMVGJL | 41.5/100Mixed-negative evidence87% evidence | BASING | 13.8/35 Revenue 21.5% · PAT 22% · OPM change -1 pp 95% evidence | 11.2/25 ROCE 15.6% · OPM 6% 95% evidence | 14.1/20 P/E 6.4× · PEG — 50% evidence | 2.4/20 RS sector -27% · RS bench -10.7% · 1Y -27%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.8 + 11.2 + 14.1 + 2.4 = 41.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 23Rajesh Exports LtdRAJESHEXPO | 29.3/100Adverse evidence91% evidence | BASING | 18.0/35 Revenue 79.5% · PAT 100% · OPM change 0 pp 74% evidence | 4.6/25 ROCE 1.9% · OPM 0% 100% evidence | 6.2/20 P/E 14.2× · PEG 1.74 100% evidence | 0.5/20 RS sector -54.8% · RS bench -44.2% · 1Y -53.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 4.6 + 6.2 + 0.5 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Asian Star Company LtdASTAR | 20.4/100Adverse evidence87% evidence | ASLEEP | 5.7/35 Revenue -3.8% · PAT -23.3% · OPM change -0.9 pp 95% evidence | 7.1/25 ROCE 3.6% · OPM 2.1% 95% evidence | 6.6/20 P/E 29× · PEG — 50% evidence | 1.0/20 RS sector -26.2% · RS bench -10.2% · 1Y -19.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 5.7 + 7.1 + 6.6 + 1 = 20.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25PNGS Reva Diamond Jewellery LimitedPNGSREVA | 59.0/100Thin evidence · provisional43% evidence | TURNING | 22.9/35 Revenue — · PAT — · OPM change 7 pp 45% evidence | 16.6/25 ROCE 22% · OPM 29% 95% evidence | 9.5/20 P/E 21.5× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 5 weeks ahead 0% evidence |
| Exact sum: 22.9 + 16.6 + 9.5 + 10 = 59 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26SJ Corporation Ltd504398 | 46.1/100Thin evidence · provisional33% evidence | 19.1/35 Revenue — · PAT — · OPM change 16.7 pp 17% evidence | 6.0/25 ROCE 0.1% · OPM 10.7% 76% evidence | 8.5/20 P/E 776× · PEG — 15% evidence | 12.5/20 RS sector — · RS bench 154.3% · 1Y —3 of 3 weeks ahead 25% evidence | |
| Exact sum: 19.1 + 6 + 8.5 + 12.5 = 46.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Shringar House of Mangalsutra Ltd's share price today?
Shringar House of Mangalsutra Ltd trades at ₹223, +17.7% over the past year. The company is valued at ₹2,153 Cr. The stock sits at 68% of its 52-week range of ₹176–₹246, +4.9% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 8 weeks in. — as of 14 August 2026.
What were Shringar House of Mangalsutra Ltd's latest quarterly results?
Shringar House of Mangalsutra Ltd reported revenue of ₹548 Cr and net profit of ₹34.0 Cr for the Jun 26 quarter. Revenue rose 64.6% and profit rose 17.2% year on year. Earnings per share were ₹3.53. The operating margin was 9.0%, 3.0 pp lower than a year earlier. — as of 14 August 2026.
What is Shringar House of Mangalsutra Ltd's revenue?
Shringar House of Mangalsutra Ltd reported revenue of ₹548 Cr in the Jun 26 quarter, +64.6% year on year. For the full FY26 fiscal year, revenue was ₹2,246 Cr (+57.1%). Over the last 5 years revenue compounded at 34.5% a year. — as of 14 August 2026.
What is Shringar House of Mangalsutra Ltd's profit?
Shringar House of Mangalsutra Ltd earned ₹34.0 Cr of net profit in the Jun 26 quarter, +17.2% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹115 Cr. The operating margin ran 9.0% in the latest quarter. — as of 14 August 2026.
What is Shringar House of Mangalsutra Ltd's market cap?
Shringar House of Mangalsutra Ltd's market capitalisation is ₹2,153 Cr at a share price of ₹223. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Shringar House of Mangalsutra Ltd's P/E ratio?
Shringar House of Mangalsutra Ltd trades at a P/E of 17.8×, at the 25th percentile of its own 1-year range, against a long-run median of 20.3×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Shringar House of Mangalsutra Ltd pay a dividend?
No — Shringar House of Mangalsutra Ltd has recorded a dividend payout of 0% of profit in each of its last 6 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 14 August 2026.
Is Shringar House of Mangalsutra Ltd overvalued?
On its own history, Shringar House of Mangalsutra Ltd looks cheap: its P/E of 17.8× has been cheaper only 25% of the time in 1 years (long-run median 20.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 14 August 2026.
Is Shringar House of Mangalsutra Ltd growing?
Yes — Shringar House of Mangalsutra Ltd is growing: latest-quarter revenue +64.6% year on year, profit +17.2%, and the margin −3.0 pp at 9.0%. The 5-year compound rates are 34.5% (revenue) and 54.7% (profit). The earnings engine currently reads: improving — as of 14 August 2026.
How is Shringar House of Mangalsutra Ltd performing?
Shringar House of Mangalsutra Ltd is in a confirmed uptrend, 8 weeks in. Its latest quarter's revenue rose 64.6% and profit rose 17.2% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
Is Shringar House of Mangalsutra Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 8 of stage 2), trading +4.9% versus its 200-day average and at 68% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Shringar House of Mangalsutra Ltd beating the market?
On recent form, yes — Shringar House of Mangalsutra Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 11 months the stock moved +18% against the NIFTY 500's +2% — ahead of the index over the full window. — as of 14 August 2026.
Will Shringar House of Mangalsutra Ltd's share price go up?
This page publishes no price forecast for Shringar House of Mangalsutra Ltd. What it measures instead: the share price is ₹223, the price is in a confirmed uptrend 8 weeks in. Its P/E of 17.8× sits at the 25th percentile of its own 1-year range. — as of 14 August 2026.
Who owns Shringar House of Mangalsutra Ltd?
Promoters hold 74.8% of Shringar House of Mangalsutra Ltd, foreign institutions 2.9%, domestic institutions 2.7% and the public 19.5% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 14 August 2026.
Does Shringar House of Mangalsutra Ltd have too much debt?
No — Shringar House of Mangalsutra Ltd's debt-to-equity is 0.28, and operating profit covers the interest bill 20×. FY26 borrowings were ₹189 Cr against equity of ₹677 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is Shringar House of Mangalsutra Ltd's capex?
Shringar House of Mangalsutra Ltd spent ₹23.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹19.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Shringar House of Mangalsutra Ltd's cash flow?
Shringar House of Mangalsutra Ltd consumed ₹282 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−301 Cr). Operating cash was negative while the company reported a profit of ₹115 Cr. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is Shringar House of Mangalsutra Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: Shringar House of Mangalsutra Ltd consumed cash while reporting profit. In FY26, operating cash was ₹−282 Cr against reported profit of ₹115 Cr. Cash-flow resolution is annual — as of 14 August 2026.
Where is Shringar House of Mangalsutra Ltd in its business cycle?
Shringar House of Mangalsutra Ltd's FY26 operating margin was 7.0%, against a 6-year band of 3.7%–7.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Shringar House of Mangalsutra Ltd story?
The sharpest disagreement: profits are rising, but only −146% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Shringar House of Mangalsutra Ltd a stock worth studying right now?
This is not investment advice. The machine read: Shringar House of Mangalsutra Ltd is coiled. The quarters are improving, yet the P/E sits at the 25th percentile of its own 1-year range — the business is moving before the market. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.